PUBLIC POLICY
ASM Policy efforts focus on communicating the importance of the microbial science to Congress, Federal Agencies and the Public.

The ASM signed onto a letter sent to House and Senate appropriations committee leaders calling on Congress to increase the fiscal 2018 302(b) subcommittee allocations for Labor-HHS.

ASM joined the Infectious Diseases Society of America (IDSA) and the Pan American Society for Clinical Virology (PASCV) in drafting comments for the draft Diagnostic Accuracy and Innovation Act (DAIA) legislation.  The DAIA builds upon previous efforts to establish a new framework for the regulation of both in vitro diagnostic tests and laboratory-developed tests (LDTs).

The ASM has compiled its funding recommendations on biomedical and life science research and public health for fiscal year 2018 in a booklet. It includes the statements sent to Congress on the federal agencies that support microbial sciences research. 

Monday, 01 May 2017 09:44

Public Policy Brief - May 1, 2017

Thursday, 13 April 2017 12:17

Public Policy Brief - April 13, 2017

The ASM submitted funding recommendations for the Department of Defense for FY 2018 to Congress.

The ASM submitted funding recommendations for the Department of Energy Office of Science for FY 2018 to Congress.

ASM activities on Capitol Hill in support of agricultural research.

The April issue of the Minority Microbiology Mentor Newsletter has been published by the Committee on Microbiological Issues Impacting Minorities.

The ASM signed onto a letter to Congress urging completion the FY 2017 appropriations process with robust investments in scientific research.

The ASM submitted funding recommendations for the US Department of Agriculture for FY 2018 to Congress.

The ASM submitted funding recommendations for the National Science Foundation for FY 2018 to Congress.

The ASM submitted funding recommendations for the Food and Drug Administration for FY 2018 to Congress.

The March issue of the Clinical Microbiology Issues Update has been published by the Office of Public Affairs.

The ASM sent a statement to members of Congress urging support for funding growth for biomedical research, science and public health programs. 

Wednesday, 22 March 2017 12:30

Public Policy Brief - March 22, 2017

Thursday, 16 March 2017 10:06

Public Policy Brief - March 16, 2017

The March issue of the Minority Microbiology Mentor Newsletter has been published by the Committee on Microbiological Issues Impacting Monorities.

Wednesday, 15 March 2017 13:13

Public Policy Brief - March 15, 2017

ASM and the Pan American Society of Clinical Virology (PASCV) drafted a letter expressing concerns about the turnaround time for results in the Zika plaque reduction neutralizing test (PRNT) currently available and suggested some solutions.   

Page 2 of 4

TPL_asm2013_ADDITIONAL_INFORMATION

TPL_asm2013_SEARCH